Frequent Dosing of Topical Cyclosporine A for Severe Ocular Surface Disease.


PURPOSE To study the systemic safety and patient tolerability of frequent dosing of cyclosporine A (CsA) 0.05% eyedrops in the treatment of ocular surface disease. This is a retrospective case series. Patients with significant ocular surface diseases who were treated using topical CsA higher than the usual twice daily dosing (3-8 times daily and over a… (More)
DOI: 10.1089/jop.2015.0078


2 Figures and Tables